Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced the appointment on April 11, 2018 of Rolf K. Hoffman, a global biopharmaceutical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE